CLIN CHEM:变性人的阴道微生物组成如何?

2019-01-04 MedSci MedSci原创

研究表明激素变化会影响阴道菌群的组成,且与个体的健康直接相关。同时,经变性为男性的睾丸激素处方激素成分不同于正常女性。但目前尚无临床研究评估睾酮给药对阴道微生物组的影响。 由自认为健康的使用处方睾酮至少1年(n = 28)的经变性男和正常女性(n = 8)自我收集阴道分泌物。参与者填写了一份调查问卷,以提供睾酮给药的模式和剂量,性病史和阴道健康状况。此外,研究人员收集血清用于激素分析。采用以

研究表明激素变化会影响阴道菌群的组成,且与个体的健康直接相关。同时,经变性为男性的睾丸激素处方激素成分不同于正常女性。但目前尚无临床研究评估睾酮给药对阴道微生物组的影响。

由自认为健康的使用处方睾酮至少1年(n = 28)的经变性男和正常女性(n = 8)自我收集阴道分泌物。参与者填写了一份调查问卷,以提供睾酮给药的模式和剂量,性病史和阴道健康状况。此外,研究人员收集血清用于激素分析。采用以16S细菌rRNA V3 V4高变异区域为靶点的广谱PCR引物、以及下一代测序和系统发育定位分析细菌群落分布。

结果表明,与正常女性相比,经变性男性的阴道菌群中乳杆菌不再作为其主要菌种。阴道内雌激素给药与经变性男性中乳酸杆菌的存在呈正相关(P = 0.045)。经变性男性的阴道菌群的相对丰度显著增加> 30种,α多样性显著增加(P = 0.0003)。乳杆菌的存在与较低的α多样性指数显著相关(P = 0.017)。

研究表明,在出生时为女性并使用睾丸激素的经变性男性的阴道微生物组可能与正常女性不同。阴道内雌激素的管理可通过促进乳杆菌属的定植和降低α多样性来减少这些差异。

原始出处:

Gabrielle Winston McPherson, Gabrielle Winston McPherson, The Vaginal Microbiome of Transgender Men

本文系梅斯医学(MedSci)原创编译整理,转载需授权!


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1825010, encodeId=df3e182501036, content=<a href='/topic/show?id=702a5065860' target=_blank style='color:#2F92EE;'>#微生物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50658, encryptionId=702a5065860, topicName=微生物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0b7c20, createdName=wjcjjian, createdTime=Fri Apr 05 02:48:00 CST 2019, time=2019-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1372018, encodeId=b1af13e20186b, content=<a href='/topic/show?id=7b4938129c3' target=_blank style='color:#2F92EE;'>#变性人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38129, encryptionId=7b4938129c3, topicName=变性人)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b53f332, createdName=marlenexl, createdTime=Sun Jan 06 06:48:00 CST 2019, time=2019-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1382400, encodeId=3dbe1382400cc, content=<a href='/topic/show?id=49d350e1625' target=_blank style='color:#2F92EE;'>#微生物组#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50716, encryptionId=49d350e1625, topicName=微生物组)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9df476, createdName=fyxzlh, createdTime=Sun Jan 06 06:48:00 CST 2019, time=2019-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1463653, encodeId=6f9c1463653a4, content=<a href='/topic/show?id=7d27381288e' target=_blank style='color:#2F92EE;'>#变性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38128, encryptionId=7d27381288e, topicName=变性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f69f6545041, createdName=huangdf, createdTime=Sun Jan 06 06:48:00 CST 2019, time=2019-01-06, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1825010, encodeId=df3e182501036, content=<a href='/topic/show?id=702a5065860' target=_blank style='color:#2F92EE;'>#微生物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50658, encryptionId=702a5065860, topicName=微生物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0b7c20, createdName=wjcjjian, createdTime=Fri Apr 05 02:48:00 CST 2019, time=2019-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1372018, encodeId=b1af13e20186b, content=<a href='/topic/show?id=7b4938129c3' target=_blank style='color:#2F92EE;'>#变性人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38129, encryptionId=7b4938129c3, topicName=变性人)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b53f332, createdName=marlenexl, createdTime=Sun Jan 06 06:48:00 CST 2019, time=2019-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1382400, encodeId=3dbe1382400cc, content=<a href='/topic/show?id=49d350e1625' target=_blank style='color:#2F92EE;'>#微生物组#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50716, encryptionId=49d350e1625, topicName=微生物组)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9df476, createdName=fyxzlh, createdTime=Sun Jan 06 06:48:00 CST 2019, time=2019-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1463653, encodeId=6f9c1463653a4, content=<a href='/topic/show?id=7d27381288e' target=_blank style='color:#2F92EE;'>#变性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38128, encryptionId=7d27381288e, topicName=变性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f69f6545041, createdName=huangdf, createdTime=Sun Jan 06 06:48:00 CST 2019, time=2019-01-06, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1825010, encodeId=df3e182501036, content=<a href='/topic/show?id=702a5065860' target=_blank style='color:#2F92EE;'>#微生物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50658, encryptionId=702a5065860, topicName=微生物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0b7c20, createdName=wjcjjian, createdTime=Fri Apr 05 02:48:00 CST 2019, time=2019-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1372018, encodeId=b1af13e20186b, content=<a href='/topic/show?id=7b4938129c3' target=_blank style='color:#2F92EE;'>#变性人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38129, encryptionId=7b4938129c3, topicName=变性人)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b53f332, createdName=marlenexl, createdTime=Sun Jan 06 06:48:00 CST 2019, time=2019-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1382400, encodeId=3dbe1382400cc, content=<a href='/topic/show?id=49d350e1625' target=_blank style='color:#2F92EE;'>#微生物组#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50716, encryptionId=49d350e1625, topicName=微生物组)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9df476, createdName=fyxzlh, createdTime=Sun Jan 06 06:48:00 CST 2019, time=2019-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1463653, encodeId=6f9c1463653a4, content=<a href='/topic/show?id=7d27381288e' target=_blank style='color:#2F92EE;'>#变性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38128, encryptionId=7d27381288e, topicName=变性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f69f6545041, createdName=huangdf, createdTime=Sun Jan 06 06:48:00 CST 2019, time=2019-01-06, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1825010, encodeId=df3e182501036, content=<a href='/topic/show?id=702a5065860' target=_blank style='color:#2F92EE;'>#微生物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50658, encryptionId=702a5065860, topicName=微生物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0b7c20, createdName=wjcjjian, createdTime=Fri Apr 05 02:48:00 CST 2019, time=2019-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1372018, encodeId=b1af13e20186b, content=<a href='/topic/show?id=7b4938129c3' target=_blank style='color:#2F92EE;'>#变性人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38129, encryptionId=7b4938129c3, topicName=变性人)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b53f332, createdName=marlenexl, createdTime=Sun Jan 06 06:48:00 CST 2019, time=2019-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1382400, encodeId=3dbe1382400cc, content=<a href='/topic/show?id=49d350e1625' target=_blank style='color:#2F92EE;'>#微生物组#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50716, encryptionId=49d350e1625, topicName=微生物组)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9df476, createdName=fyxzlh, createdTime=Sun Jan 06 06:48:00 CST 2019, time=2019-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1463653, encodeId=6f9c1463653a4, content=<a href='/topic/show?id=7d27381288e' target=_blank style='color:#2F92EE;'>#变性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38128, encryptionId=7d27381288e, topicName=变性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f69f6545041, createdName=huangdf, createdTime=Sun Jan 06 06:48:00 CST 2019, time=2019-01-06, status=1, ipAttribution=)]
    2019-01-06 huangdf

相关资讯

男人5年内可以拥有子宫

男人有可能生孩子吗?上周克利夫兰临床医院的一项手术引发了针对这一问题的广泛讨论。这是一台子宫移植手术,患者是一名子宫功能丧失导致无法生育的女性。看到这则消息,我们心里可能都会猜想:既然子宫可以移植给女性,那是否也可以移植给男性呢? 答案是肯定的。理论上,男性可以接受子宫移植,并怀孕生育宝宝。然而,这一天这么快到来依然会令我们难以接受。 "我认为在未来5到10年之间,或许更快,男性子宫移植手

JCEM:接受性激素疗法对变性人心血管健康的影响如何?

尽管对心血管健康存在有限的作用,跨性别者(俗称,变性人)接受交叉性激素治疗以产生所需的第二性征。但这种治疗方案对他们的心血管结局有着怎样的具体影响?来自美国的研究人员进行了一项系统回顾和荟萃分析。

JCEM:接受性激素疗法对变性人骨骼健康的影响如何?

跨性别者(俗称,变性人)接受交叉性激素治疗以产生所需的第二性征,但变性人接受性激素疗法后对其骨健康的影响尚不清楚。来自美国的研究人员对此进行了一项系统回顾和荟萃分析。

特朗普:禁止变性人服役 因为医疗成本太高

变性人服役为医疗成本高“背锅”,冤不冤?

JCEM:一年跨性别激素治疗后变性人乳房发育情况

众所周知乳房是女性化的重要标志之一,因此对于变性人(男性到女性的变性人)而言相当重要。但是,目前关于在初始跨性别激素治疗(CHT)之后乳房什么时候开始发育及能发育至何程度还尚未可知。2017年11月20日在JCEM杂志上发表的一篇文章则旨在探讨变性人在CHT第一年间乳腺发育及罩杯大小的变化,以及是否存在临床或实验室的参数可以估计乳腺发育情况。

J Adolesc Health:变性人心理问题谁人知?

“我们现在可以明确给出一个答复,变性人的出现不是由于荷尔蒙分泌失衡。”本文的作者洛杉矶儿童医院的Johanna Olson 博士对此坚定不移。Olson博士和他的同事们进行的这项研究,重点关注的是评估帮助跨性别病人确定性别这一治疗措施的安全性和有效性及变性人的心理问题。处于青春期的变性人可以用促性腺激素释放激素(GnRH)类似物治疗,以抑制并延迟身体在青春期产生的物理变化。当人们觉得自己的性别身份